SCHEMBL20334271

SCHEMBL20334271

O=C1c2ccccc2C(=O)c2c(NC(CO)C(=O)O)ccc(NC(CO)C(=O)O)c21

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 4/20 0.53
MEN1 O00255 3/20 0.53
NSD2 O96028 1/20 0.53
POLB P06746 1/20 0.53
BLM P54132 1/20 0.53
RXFP1 Q9HBX9 1/20 0.53
PKLR P30613 2/20 0.52
TOP2B Q02880 1/20 0.48
MMP14 P50281 1/20 0.44
TERT O14746 5/20 0.43
NPC1 O15118 2/20 0.42
RAB9A P51151 2/20 0.42
MTOR P42345 1/20 0.42
SIRT2 Q8IXJ6 1/20 0.42
MME P08473 1/20 0.41
LMNA P02545 2/20 0.41
MAPT P10636 2/20 0.41
L3MBTL1 Q9Y468 2/20 0.41
MAPK1 P28482 1/20 0.41
NPSR1 Q6W5P4 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12984801 0.81 ALDH1A1 (0.49) KMT2AMEN1RAB9ALMNAMAPT
SCHEMBL9545868 0.76 MAPT (0.46) KMT2AMEN1NSD2POLBBLM
SCHEMBL27984229 0.75 PPARG (0.53) KMT2AMEN1POLBPKLRRAB9A
SCHEMBL27983863 0.74 MAOA (0.54) KMT2AMEN1POLBBLMPKLR
SCHEMBL7561830 0.73 RAB9A (0.47) POLBNPC1RAB9ALMNAMAPT
SCHEMBL3276898 0.73 HDAC1 (0.46) KMT2AMEN1NPC1RAB9AMME
SCHEMBL679864 0.73 RAB9A (0.47) POLBNPC1RAB9ALMNAMAPT
SCHEMBL27623107 0.73 HTT (0.45) KMT2AMEN1NPC1RAB9AMME
SCHEMBL3488827 0.73 MME (0.45) KMT2AMEN1POLBRAB9AMME
SCHEMBL344918 0.73 MME (0.45) KMT2AMEN1POLBRAB9AMME

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230240954-A1 USE OF ANTHRAQUINONE DYES AND OF FLUORESCENT DYES FOR DYEING KERATIN FIBRES, DYEING PROCESS AND COMPOSITION L'OREAL (FR) 2023-08-03 US disclosed
US-20230240954-A1 USE OF ANTHRAQUINONE DYES AND OF FLUORESCENT DYES FOR DYEING KERATIN FIBRES, DYEING PROCESS AND COMPOSITION L'OREAL (FR) 2023-08-03 US disclosed
EP-3558235-B1 USE OF ANTHRAQUINONE DYES AND OF FLUORESCENT DYES FOR DYEING KERATIN FIBRES, DYEING PROCESS AND COMPOSITION OREAL (FR) 2021-09-08 EP disclosed
WO-2018115337-A1 USE OF ANTHRAQUINONE DYES AND OF FLUORESCENT DYES FOR DYEING KERATIN FIBRES, DYEING PROCESS AND COMPOSITION L'OREAL (FR) 2018-06-28 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230240954-A1 USE OF ANTHRAQUINONE DYES AND OF FLUORESCENT DYES FOR DYEING KERATIN FIBRES, DYEING PROCESS AND COMPOSITION KRT18, CUTA, KLK5 KMT2A 2181/4885MEN1 2794/4885NSD2 2000/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.